Peptides Archives

In Depth 28 May 2025

New weight loss drugs: Biotech’s mission to end obesity

Find out more about biotech’s mission to end obesity, as we look at the new weight loss drugs that are in development.

May 28, 2025 - 17 minutesmins - By Willow Shah-Neville

News and Trends 7 May 2025

Top biotech deals of April 2025

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and drug delivery.

May 7, 2025 - 9 minutesmins - By Roohi Mariam Peter

In Depth 14 Mar 2025

Can GLP-1 agonists help treat addiction?

Discover how researchers have been exploring the potential of GLP-1 drugs for treating addiction disorders.

March 14, 2025 - 9 minutesmins - By Willow Shah-Neville

In Depth 2 Dec 2024

The rise of cancer vaccines: A new era in immunotherapy

Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight tumors.

December 2, 2024 - 8 minutesmins - By Jules Adam

Best in Biotech 14 Oct 2024

Six biomimicry biotech companies harnessing nature’s wisdom to develop breakthrough drug candidates

Find out more about six biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human health.

October 14, 2024 - 8 minutesmins - By Willow Shah-Neville

In Depth 7 Oct 2024

Spinal cord injury: Are we getting closer to a treatment?

Delve into the spinal cord injury treatment landscape with a few pharmaceutical approaches that could tackle this complex condition.

October 7, 2024 - 8 minutesmins - By Jules Adam

Sublingual delivery of GLP-1 receptor agonists

Sublingual delivery: the future for GLP-1 receptor agonists

Discover how GLP-1 receptor agonists, now thriving in obesity treatment, could benefit from a more patient-friendly sublingual delivery method.

October 1, 2024 - 7 minutesmins - By External Contributor

In Depth 25 Sep 2024

How Pfizer’s decision in the ’90s cost them a stronghold in the GLP-1 market

Discover an untold biotech story and find out how Pfizer missed an opportunity in the GLP-1 market because of an exit in the ’90s.

September 25, 2024 - 9 minutesmins - By Jennifer Tsang

Best in Biotech 5 Sep 2024

Six biotech companies that could revolutionize obesity treatments

In this article, we take a look at six biotechs focused on bringing drugs to treat obesity to the market.

September 5, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 28 Aug 2024

GLP-1 shortage: Can biotech companies keep up with rising demand?

How is the biotech industry responding to the GLP-1 drug shortage? We asked experts in the field to answer this question.

August 28, 2024 - 6 minutesmins - By Roohi Mariam Peter

KBI Biopharma microbial CLD 16JUL2024 article labiotech main illustration

How a microbial expression update is driving biotech innovation

Discover how microbial expression systems are revolutionizing protein production for next-gen therapies like antibodies and peptides.

July 16, 2024 - 7 minutesmins - By Ute Boronowsky

In Depth 25 Mar 2024

Beyond Wegovy: Could Novo Nordisk’s new experimental weight loss pill be even better?

Discover how Novo Nordisk’s new experimental obesity pill, amycretin, could be even more efficient for weight loss than Wegovy.

March 25, 2024 - 4 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Peptides

New weight loss drugs: Biotech’s mission to end obesity

Top biotech deals of April 2025

Can GLP-1 agonists help treat addiction?

The rise of cancer vaccines: A new era in immunotherapy

Six biomimicry biotech companies harnessing nature’s wisdom to develop breakthrough drug candidates

Spinal cord injury: Are we getting closer to a treatment?

Sublingual delivery: the future for GLP-1 receptor agonists

How Pfizer’s decision in the ’90s cost them a stronghold in the GLP-1 market

Six biotech companies that could revolutionize obesity treatments

GLP-1 shortage: Can biotech companies keep up with rising demand?

How a microbial expression update is driving biotech innovation

Beyond Wegovy: Could Novo Nordisk’s new experimental weight loss pill be even better?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!